Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-23 Purchase |
2021-03-23 3:57 pm |
Cardiff Oncology Inc. | CRDF | JACOB GARY S Director |
2,370 | $10.42 | $24,689 | 21,922 (Direct) |
View |
| 2021-03-23 Purchase |
2021-03-23 2:30 pm |
Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO |
960 | $10.31 | $9,898 | 6,053 (Direct) |
View |
| 2021-03-23 Purchase |
2021-03-23 12:24 pm |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
965 | $10.34 | $9,980 | 14,481 (Direct) |
View |
| 2021-03-22 Purchase |
2021-03-22 6:35 pm |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director |
3,000 | $10.95 | $32,850 | 12,260 (Direct) |
View |
| 2021-03-18 Purchase |
2021-03-19 11:34 am |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
3,000 | $10.55 | $31,660 | 454,811 (Direct) |
View |
| 2021-03-04 Purchase |
2021-03-04 8:46 pm |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
1,500 | $9.265 | $13,898 | 451,811 (Direct) |
View |
| 2020-11-23 Sale |
2020-11-25 4:02 pm |
Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO |
35,321 | $18.6 | $657,020 | 75,695 (Direct) |
View |
| 2020-09-16 Purchase |
2020-09-17 09:42 am |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
2,550 | $5.6967 | $14,527 | 450,311 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-02 Tax Withholding |
2021-01-05 4:04 pm |
N/A N/A |
Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO |
31 | $0 | 5,093 (Direct) |
View |
| 2021-01-02 Exercise |
2021-01-05 4:04 pm |
N/A N/A |
Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO |
70 | $0 | 5,093 (Direct) |
View |
| 2021-01-02 Tax Withholding |
2021-01-05 4:03 pm |
N/A N/A |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
113 | $0 | 13,516 (Direct) |
View |
| 2021-01-02 Exercise |
2021-01-05 4:03 pm |
N/A N/A |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
260 | $0 | 13,516 (Direct) |
View |
| 2020-11-23 Exercise |
2020-11-25 4:02 pm |
N/A 2029-06-20 |
Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO |
35,321 | $2.48 | 75,695 (Direct) |
View |
Ownership |
2020-10-02 4:30 pm |
N/A N/A |
Cardiff Oncology Inc. | CRDF | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 3,290,000 (Indirect) |
View |